Vitrakvi Side Effects

Generic name: larotrectinib

Medically reviewed by Drugs.com. Last updated on Jul 24, 2024.

Note: This document provides detailed information about Vitrakvi Side Effects associated with larotrectinib. Some dosage forms listed on this page may not apply specifically to the brand name Vitrakvi.

Applies to larotrectinib: oral capsule, oral solution.

Serious side effects of Vitrakvi

Along with its needed effects, larotrectinib (the active ingredient contained in Vitrakvi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking larotrectinib:

More common side effects

• being forgetful
• black, tarry, stools
• bladder pain
• bloating or swelling of the face, arms, hands, lower legs, or feet
• bloody or cloudy urine
• blurred vision
• chest tightness
• chills
• confusion as to time, place, or person
• cough
• difficult, burning, or painful urination
• discouragement
• dizziness
• falls
• fear, nervousness
• feeling sad or empty
• fever
• frequent urge to urinate
• headache
• holding false beliefs that cannot be changed by fact
• irritability
• lack of appetite
• loss of interest or pleasure
• loss of memory
• lower back or side pain
• nervousness
• painful or difficult urination
• pale skin
• pounding in the ears
• problems with memory
• problems with speech or speaking
• rapid weight gain
• seeing, hearing, or feeling things that are not there
• sleepiness or unusual drowsiness
• slow or fast heartbeat
• sore throat
• tingling of the hands or feet
• trouble breathing
• trouble concentrating
• trouble sleeping
• ulcers, sores, or white spots in the mouth
• unusual bleeding or bruising
• unusual excitement, nervousness, or restlessness
• unusual tiredness or weakness
• unusual weight gain or loss

Less common side effects

• chest pain or discomfort
• confusion
• decreased urination
• diarrhea
• dry mouth
• fainting
• heartburn
• increase in heart rate
• increased thirst
• indigestion
• irregular heartbeat
• itching, pain, redness, swelling, tenderness, or warmth on the skin
• lightheadedness
• loss of consciousness
• muscle pain, cramps, or weakness
• nausea
• problems with movement or walking
• rapid, shallow breathing
• seizures
• severe stomach pain, cramping, or burning
• sunken eyes
• swelling of the face, ankles, or hands
• vomiting
• vomiting of material that looks like coffee grounds, severe and continuing
• wrinkled skin
• yellow skin or eyes

Other side effects of Vitrakvi

Some side effects of larotrectinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• back pain
• constipation
• decreased appetite
• difficulty in moving
• increased weight
• joint pain or swelling
• muscle stiffness
• pain in the arms or legs
• stuffy nose

Less common side effects

• lack or loss of strength

For healthcare professionals

Applies to larotrectinib: oral capsule, oral solution.

General adverse events

The most common adverse reactions (20% or greater) were fatigue, nausea, dizziness, vomiting, anemia, increased AST, cough, increased ALT, constipation, and diarrhea.^[Ref]

Musculoskeletal

• Very common (10% or more): Arthralgia (14%), myalgia (14%), muscular weakness (13%), back pain (12%), pain in extremity (12%)^[Ref]

Metabolic

• Very common (10% or more): Peripheral edema (15%), increased weight (15%), decreased appetite (13%)^[Ref]

Psychiatric

• Common (1% to 10%): Delirium, memory impairment^[Ref]

Hepatic

• Very common (10% or more): Hepatotoxicity (45%), Increased ALT (45%), increased AST (45%), increased alkaline phosphatase (30%)^[Ref]

Respiratory

• Very common (10% or more): Cough (26%), dyspnea (18%), nasal congestion (10%)^[Ref]

Other

• Very common (10% or more): Fatigue (37%), pyrexia (18%), fall (10%)^[Ref]

Hematologic

• Very common (10% or more): Anemia (42%), hypoalbuminemia (35%), neutropenia (23%)^[Ref]

Nervous system

• Very common (10% or more): Neurotoxicity (53%), dizziness (28%), headache (14%)
• Common (1% to 10%): Dysarthria, gait disturbance, tremor, paresthesia
• Uncommon (0.1% to 1%): Grade 4 encephalopathy^[Ref]

Cardiovascular

• Very common (10% or more): Hypertension (11%)^[Ref]

Gastrointestinal

• Very common (10% or more): Nausea (29%), vomiting (26%), constipation (23%), diarrhea (22%), abdominal pain (13%)^[Ref]

Frequently asked questions

• What type of drug is Vitrakvi (larotrectinib)?

Further information

Vitrakvi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer